Neutralizes oxidative stress and inflammation
One phase two trial (mean age 58, with no upper age limit) demonstrated mean reduction in body weight of 15.6% in participants taking CagriSema, compared to 5.1% and 8.1% with semaglutide and cagrilintide in monotherapy, respectively, over 32 weeks
Key Features Sterile, non-pyrogenic diluent for injection Contains 0.9% benzyl alcohol preservative Multi-dose vial for repeated use 30 mL volume Designed for dilution or reconstitution of injectable medications Suitable for professional medical use Common Uses Reconstituting medications Diluting injectable drugs Clinical and healthcare facility applications **Note Sterile and latex free Store between 20 and 25 degree
Karim PL, Nopriyati IAA
doi: 10.3389/fbioe.2021.677576 Received 07 March 2021 Accepted 12 April 2021 Published 29 April 2021 Volume 9 - 2021 Edited by Zhen Li, AO Research Institute, Switzerland Reviewed by Guangli Suo, Suzhou Institute of Nano-tech and Nano-bionics (CAS), China
For instance, N-Acetyl-Nle-Tyr-Ile-His had a half-life of 115 7.6 min, D-Nle-Tyr-Ile showed 225 23.7 min, and GABA-Tyr-Ile exhibited a remarkable 946 234 min
